Trials / Sponsors / ModeX Therapeutics, An OPKO Health Company
ModeX Therapeutics, An OPKO Health Company
Industry · 4 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19. COVID -19, COVID-19 (Prevention) | Phase 1 | 2026-03-01 |
| Recruiting | Dose Escalation and Dose Expansion Study of MDX2003 in Patients With Different Types of Lymphoma Lymphoma, Waldenström Macroglobulinemia (WM), DLBCL - Diffuse Large B Cell Lymphoma | Phase 1 / Phase 2 | 2026-03-01 |
| Recruiting | Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors Advanced Tumors | Phase 1 / Phase 2 | 2025-10-01 |
| Recruiting | Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors Biliary Tract Cancer, Breast Cancer, Cervical Cancer | Phase 1 / Phase 2 | 2024-06-12 |